Immunization with vaccinia virus recombinants that express the surface glycoproteins of human parainfluenza virus type 3 (PIV3) protects patas monkeys against PIV3 infection
Data up to Jan 2025
Total Citations Per Year
Abstract
References (23)
Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity by proteolytic cleavage of an inactive precursor protein of Sendai virus
1974 • 931 citations
Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques.
1985 • 789 citations
Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes.
1985 • 526 citations
Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen
1983 • 422 citations
Isolation of paramyxovirus glycoproteins. Association of both hemagglutinating and neuraminidase activities with the larger SV5 glycoprotein
1972 • 330 citations
Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity.
1986 • 317 citations
Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters.
1983 • 296 citations
Live recombinant vaccinia virus protects chimpanzees against hepatitis B
1984 • 290 citations
Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats
1985 • 247 citations
ASSOCIATION OF A NEW TYPE OF CYTOPATHOGENIC MYXOVIRUS WITH INFANTILE CROUP
1956 • 212 citations
Vaccinia Virus Expression Vectors
1986 • 184 citations
Fusion glycoprotein of human parainfluenza virus type 3: Nucleotide sequence of the gene, direct identification of the cleavage-activation site, and comparison with other paramyxoviruses
1986 • 131 citations
Expression of the F and HN glycoproteins of human parainfluenza virus type 3 by recombinant vaccinia viruses: contributions of the individual proteins to host immunity
1987 • 129 citations
Analysis of immunoglobulin G antibody responses after administration of live and inactivated influenza A vaccine indicates that nasal wash immunoglobulin G is a transudate from serum
1987 • 126 citations
Resistance to human respiratory syncytial virus (RSV) infection induced by immunization of cotton rats with a recombinant vaccinia virus expressing the RSV G glycoprotein.
1986 • 117 citations
Immunoglobulins in Serum and Nasal Secretions Following Infection with Type 1 Parainfluenza Virus and Injection of Inactivated Vaccines
1967 • 102 citations
Conserved epitopes on the hemagglutinin-neuraminidase proteins of human and bovine parainfluenza type 3 viruses: nucleotide sequence analysis of variants selected with monoclonal antibodies
1986 • 100 citations
Human parainfluenza type 3 virus hemagglutinin-neuraminidase glycoprotein: nucleotide sequence of mRNA and limited amino acid sequence of the purified protein
1986 • 84 citations
Human parainfluenza virus type 3: messenger RNAs, polypeptide coding assignments, intergenic sequences, and genetic map
1986 • 84 citations
THE TECUMSEH STUDY OF RESPIRATORY ILLNESS
1973 • 73 citations
Structural characterization of virion proteins and genomic RNA of human parainfluenza virus 3
1984 • 71 citations
Parainfluenza Virus Immunization: II. The Influence of Age and Maternal Antibody upon Successful Immunization with an Alum-Adsorbed Parainfluenza Type 3 Vaccine
1967 • 16 citations
Parainfluenza Virus Immunization
1967 • 8 citations
Cited By (0)
No citing papers found in database